Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis
Description
CONCLUSION: The Kaplan-Meier survival analysis did not show a survival benefit of exenteration at 3 months and 6 months in COVID-associated rhino-orbital mucormycosis.
